tirzepatide mash fda 🎉Exciting news that Semaglutide is now approved for (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Wegovy becomes first GLP-1RA to

Free tracked shipping across Canada with free express shipping on orders over $300

It can also convert glucose into energy that help the body eliminate harmful toxins

Highlights of Prescribing Information - MOUNJARO Highlights of Prescribing Information - OZEMPIC Highlights of Prescribing Information - WEGOVY Highlights of Prescribing Information - ZEPBOUND Once-Weekly Semaglutide in Adults with Overweight or Obesity - The New England Journal of Medicine The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials - Diabetes Therapy Tirzepatide as Compared with Semaglutide for the Treatment of Obesity - The New England Journal of Medicine Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes - The New England Journal of Medicine Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and MetaAnalysis of Direct Comparative Studies - Endocrinology, Diabetes & Metabolism

For HS patients using a GLP-1 RA for six months, the researchers found: Less severe HS: 54% of participants improved by one point and 12% improved by two or more points on the HS-PGA (Hidradenitis Suppurativa Physician Global Assessment) scale, which measures general severity of HS on a scale from 0 to 5

Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial

Skip the fries